Assessing STEMI Outcomes in Patients With Cancer A Call for Integrated Cardiovascular and Cancer Phenotyping

被引：0
|
作者：
Asnani, Aarti [1 ,3 ]
Wadhera, Rishi K. [2 ]
Yeh, Robert W. [2 ,4 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Cardiooncol Sect, Boston, MA USA
[2] Richard A & Susan F Smith Ctr Outcomes Res, Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Beth Israel Deaconess Med Ctr, 3 Blackfan Circle,CLS-911, Boston, MA 02115 USA
[4] Harvard Med Sch, 375 Longwood Ave,4th Floor, Boston, MA 02214 USA
来源：
JACC: CARDIOONCOLOGY | 2024年 / 6卷 / 01期
关键词：
acute coronary syndrome; cancer; cardio-oncology; myocardial infarction;
D O I：
10.1016/j.jaccao.2023.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：130 / 132
页数：3
相关论文
共 50 条
  • [41] Clinical Outcomes of Sidewall/Parametrial Simultaneous Integrated Boost for Patients with Cervical Cancer
    Huang, C. C.
    Niedzwiecki, D.
    Wan, Z.
    Chino, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E519 - E519
  • [42] Letter: Cancer Paradox and Short-term STEMI-related Outcomes
    Yilmaz, Omer Faruk
    Sener, Yusuf Ziya
    ANGIOLOGY, 2025,
  • [43] Trends, untilization of therapies and outcomes of females with history of breast cancer admitted for STEMI
    Mastoris, I.
    Shah, Z.
    Vuddanda, V.
    Mohammed, M.
    Haglund, N.
    Sauer, A.
    Porter, C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2074 - 2074
  • [44] Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer
    D. de Wit
    H. Gelderblom
    A. Sparreboom
    J. den Hartigh
    M. den Hollander
    J. M. C. König-Quartel
    T. Hessing
    H. J. Guchelaar
    N. P. van Erp
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 87 - 96
  • [45] Comprehensive Phenotyping of Dendritic Cells in Cancer Patients by Flow Cytometry
    Carenza, Claudia
    Franzese, Sara
    Calcaterra, Francesca
    Mavilio, Domenico
    Della Bella, Silvia
    CYTOMETRY PART A, 2021, 99 (03) : 218 - 230
  • [46] Temporal electronic phenotyping by mining careflows of breast cancer patients
    Dagliati, A.
    Sacchi, L.
    Zambelli, A.
    Tibollo, V.
    Pavesi, L.
    Holmes, J. H.
    Bellazzi, R.
    JOURNAL OF BIOMEDICAL INFORMATICS, 2017, 66 : 136 - 147
  • [47] Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer
    de Wit, D.
    Gelderblom, H.
    Sparreboom, A.
    den Hartigh, J.
    den Hollander, M.
    Konig-Quartel, J. M. C.
    Hessing, T.
    Guchelaar, H. J.
    van Erp, N. P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 87 - 96
  • [48] Assessing patients' satisfaction and intensity of pain as outcomes in the management of cancer-related pain
    Panteli, Vasiliki
    Evangelia, Patistea
    Athanasia, Goula
    Epaminondas, Sarnantas
    PSYCHO-ONCOLOGY, 2008, 17 : S218 - S219
  • [49] Assessing patients' satisfaction and intensity of pain as outcomes in the management of cancer-related pain
    Panteli, Vassiliki
    Patistea, Evangelia
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2007, 11 (05) : 424 - 433
  • [50] Assessing Clinical Frailty in Advanced Lung Cancer Patients - An Opportunity to Improve Patient Outcomes?
    Gomes, F.
    Baker, K.
    Woods, J.
    Bruce, J.
    Eaton, M.
    Higham, P.
    Cove-Smith, L.
    Garbett, A.
    Cree, A.
    Ng, C.
    Blackhall, F.
    Bayman, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S329 - S329
12345